413 related articles for article (PubMed ID: 17394811)
1. [Biological dermatologic agents. The Danish Society of Dermatology].
Iversen L; Kragballe K;
Ugeskr Laeger; 2007 Mar; 169(12):1100. PubMed ID: 17394811
[No Abstract] [Full Text] [Related]
2. [Biologics in skin diseases other than psoriasis].
Gniadecki R; Skov L
Ugeskr Laeger; 2008 Jun; 170(24):2126-8. PubMed ID: 18565293
[TBL] [Abstract][Full Text] [Related]
3. [Dermatologic treatment. The Danish Society of Dermatology].
Olesen AK; Jemec GB
Ugeskr Laeger; 2003 Mar; 165(12):1228. PubMed ID: 12701278
[No Abstract] [Full Text] [Related]
4. Rituximab: a B-cell depletion therapy for dermatologic disease.
Prajapati V; Mydlarski PR
Skin Therapy Lett; 2007; 12(6):6-9. PubMed ID: 17762903
[TBL] [Abstract][Full Text] [Related]
5. [Biological therapeutic agents and patient autonomy in dermatologic therapy. The Danish Society of Dermatology].
Bygum A; Jemec GB
Ugeskr Laeger; 2004 Mar; 166(12):1105. PubMed ID: 15067764
[No Abstract] [Full Text] [Related]
6. Rituximab: applications in dermatology.
Fatourechi MM; el-Azhary RA; Gibson LE
Int J Dermatol; 2006 Oct; 45(10):1143-55; quiz 1155. PubMed ID: 17040427
[TBL] [Abstract][Full Text] [Related]
7. A host of novel agents for treating psoriasis, psoriatic arthritis stir interest.
Lamberg L
JAMA; 2003 Jun; 289(21):2779-80, 2783. PubMed ID: 12783895
[No Abstract] [Full Text] [Related]
8. Treatment of inflammatory dermatoses with novel biologic agents: a primer.
Nussbaum R; Krueger JG
Adv Dermatol; 2002; 18():45-89. PubMed ID: 12528402
[No Abstract] [Full Text] [Related]
9. Consecutive use of different biological therapies in the treatment of psoriasis.
Costanzo A; Papoutsaki M; Mazzotta A; Chimenti S
Br J Dermatol; 2007 Aug; 157(2):394. PubMed ID: 17553044
[No Abstract] [Full Text] [Related]
10. Biologic agents in psoriasis.
Lee MR; Cooper AJ
Australas J Dermatol; 2006 Nov; 47(4):217-29; quiz 229-30. PubMed ID: 17034462
[TBL] [Abstract][Full Text] [Related]
11. Cytokines in dermatology.
Holman DM; Kalaaji AN
J Drugs Dermatol; 2006 Jun; 5(6):520-4. PubMed ID: 16774103
[TBL] [Abstract][Full Text] [Related]
12. [Dermatologic phototherapy].
Krutmann J
Hautarzt; 1991 Jun; 42(6):407-14. PubMed ID: 1917466
[No Abstract] [Full Text] [Related]
13. Residents' corner September 2011. Residents' editorial choice.
Feldmeyer L; Guenova E; Torres T; Nosbaum A
Eur J Dermatol; 2011; 21(5):826-7. PubMed ID: 21914583
[No Abstract] [Full Text] [Related]
14. Observational case series on a group of patients with severe psoriasis who failed to respond to antitumour necrosis factor alpha biologics and switched to ustekinumab.
Downs AM
Br J Dermatol; 2010 Aug; 163(2):433-4. PubMed ID: 20456344
[No Abstract] [Full Text] [Related]
15. [Dermatology--new therapeutic possibilities. The Danish Society of Dermatology].
Gniadecki R; Haedersdal M
Ugeskr Laeger; 2006 Mar; 168(12):1213. PubMed ID: 16571304
[No Abstract] [Full Text] [Related]
16. [Biotechnological pharmaceuticals and their potential use in inflammatory skin diseases].
Villadsen L; Baadsgaard O
Ugeskr Laeger; 2000 Dec; 162(50):6820-4. PubMed ID: 11187134
[TBL] [Abstract][Full Text] [Related]
17. Beyond Psoriasis: Novel Uses for Biologic Response Modifiers in Pediatric Dermatology.
Bellodi-Schmidt F; Shah KN
Pediatr Dermatol; 2016; 33(1):18-27. PubMed ID: 26607958
[TBL] [Abstract][Full Text] [Related]
18. Off-label uses of rituximab in dermatology.
Carr DR; Heffernan MP
Dermatol Ther; 2007; 20(4):277-87. PubMed ID: 17970893
[TBL] [Abstract][Full Text] [Related]
19. Cutaneus pseudolymphoma: a case report.
Dragonetti E; Cianchini G; Mastrangelo L; Mellone P; Baldi A
In Vivo; 2004; 18(5):549-51. PubMed ID: 15523891
[TBL] [Abstract][Full Text] [Related]
20. Experimental therapies in the treatment of cutaneous T-cell lymphoma.
Foss FM; Kuzel TM
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1127-37. PubMed ID: 8522489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
